Member Info for skittish

ASOS - 100x - 1000x - woodaldo it wasn't a typo - ASOS was 6p at one point and then went to 70000p+ at one point.

I wasn't in, but I did watch, continually thinking I'd missed the boat.

Now around £20 but at one point it did do 1000X!

Anything can happen in these unusual times.

(Not saying NCYT will do 1000x mind - but I have a feeling we are only at the earlier stages of a crisis and it will be well into 2021 before matters return to what will then be a new "normal".)

About those Middle East sales........

https://www.withinnigeria.com/2020/04/09/covid-19-saudi-arabias-king-in-isolation-after-150-members-of-the-royal-family-reportedly-test-positive/

This spike was very similar to the spike on 17th February 2020, when the share price went from around 100p to 225p in an hour or so before closing around 150p.

The share fell back significantly over the next few days to well below 100p.

The difference between then and now is that COVID19 then was a virus in far away lands and no one had died in the UK.

Now UK deaths are 1000+ every day (notwithstanding the official figures) , NCYT have AZN and GSK tapping them for their knowledge and patents and the country is in crisis.

This time, because circumstances are different and the pandemic more immediate I doubt we will get much more pull back, but just as before we will achieve new highs well in excess of those attained earlier.

I suspect it won't be long before we blast through 517p and keep going.

I don't think so.

Will be interesting to watch.

€4.40 in Paris = 385p - going for it again?

Would think they will have to RNS "something" - it was 125p only last week!

Paris €5.30 = 464p

Paris €4.98 = 436p

4.53 in Paris = 397p

Breaking to the upside now.

Ascending triangle about to break?

Possibly a significant move upwards if it does.

Seller finally exhausted?

I wouldn't say investing in here is a mistake.

There does appear to be a big seller, and a locked in shareholder will no longer be locked in after 22nd April so the possibility of another seller exists. Their supply of shares is not limitless however, whereas the supply of COVID cases, at present is unfortunately, limitless.

However NCYT appear to be critical to the UK (and international COVID) efforts at present so any company in with them at the present time should do well.

I guess the thing to do is position appropriately.

Any share with a COVID RNS appears to instantly go up 50%.

YGEN I'm sure will get its own RNS in due course - we are due an update anyway.

Patience is a virtue. I'm also in NCYT.

Small mention in The times lunchtime edition. Likely to get a mention in print tomorrow.

"Novacyt said that it would provide its test to the laboratory to generate results data.

It said last month that it had sold and received orders for more than £17.8 million of tests and that its test was being sold to more than 80 countries.

Novcayt has been stepping up its manufacturing and distribution capacity and last month signed a manufacturing services agreement with Yourgene, a Manchester-based diagnostics company. It is in talks with an additional UK-based third-party manufacturer"

https://www.thetimes.co.uk/edition/business/who-fast-tracks-british-antigen-test-tj7db7m60?utm_medium=Social&utm_source=Twitter#Echobox=1586353317

Snippets from The Times lunchtime online edition. Likely to get another mention in print tomorrow - maybe with an amended recommendation?

https://www.thetimes.co.uk/edition/business/who-fast-tracks-british-antigen-test-tj7db7m60?utm_medium=Social&utm_source=Twitter#Echobox=1586353317

"A test for Covid-19 developed by a British-listed biotech company has been fast-tracked by the World Health Organisation.

Novacyt’s Primerdesign subsidiary is developing the test — which identifies people showing symptoms — in Southampton and it has been listed as eligible for emergency use for one year by WHO.

The listing is designed to accelerate the availability of the test to help procurement agencies and countries that have not yet approved the device.

There are only two companies listed by WHO for Covid-19 tests. Roche, the Swiss-based multinational, was listed last week. WHO developed the process in response to the 2014 ebola outbreak."

"The Anne McLaren lab is a new facility based on the biomedical campus in the south of the city, which is where Astrazeneca is building its new £1 billion global headquarters. The lab will also explore the use of alternative chemical reagents for test kits to help to overcome supply shortages.

Sources said that there had been caution at Glaxo that the facility would only be fully operational by early next month, when it is looking to produce tests in their low thousands.

However, Pascal Soriot, the chief executive of Astrazeneca, told BBC Radio 4 this morning that it could “scale with 30,000 tests a day by early May”."

It has now!

Unusually perky today?

I got the impression from the webinar yesterday that YGEN staff were working in shifts so as to maximise lab production.

If so they are probably going all out at this time - also noticed that Hayden appeared to be texting on his phone from time to time during the webinar so all staff appear to be busy.

The new NCYT COVID lab will be in Cambridge but this will be inappropriate for mass testing in northern hospitals.

As YGEN is already testing for the NHS, and is located within half a mile of 4 major hospitals (St Mary's Hospital, Manchester Royal Infirmary, Royal Manchester Childrens Hospital, Manchester University NHS Foundation Trust) it would make sense for YGEN's labs or staff to be the foundation for a northern COVID testing hub.

I suspect we will have our day in the sun.

Two charts show that matters are more serious than the government admits.

Firstly deaths are 80% higher than the official daily COVID total -

https://ibb.co/hR3bZDT

Secondly there is a massive spike in infections in old folks homes - I suspect many of these deaths are not recorded as COVID deaths at all -

https://ibb.co/SKKc2Nh

Pile it high - sell it cheap!

Winning formula.

We are now international and at scale thanks to our new partners.

Peston now tweeting about NCYT!